Exact Mass: 614.0907812

Exact Mass Matches: 614.0907812

Found 44 metabolites which its exact mass value is equals to given mass value 614.0907812, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Castacrenin A

12-[4-(1,2-dihydroxyethyl)-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0543978000001)

Castacrenin A is found in nuts. Castacrenin A is a constituent of the heartwood of Castanea crenata (Japanese chestnut)

2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose

(3,4-Dihydroxy-5-{[(2Z)-3-phenylprop-2-enoyl]oxy}-6-(3,4,5-trihydroxybenzoyloxy)oxan-2-yl)methyl 3,4,5-trihydroxybenzoic acid

C29H26O15 (614.1271646)

2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is found in green vegetables. 2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is isolated from commercial rhubarbs (Rheum sp.). Isolated from commercial rhubarbs (Rheum species). 2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is found in green vegetables.

Castacrenin C

6,7,13,14-tetrahydroxy-5-[5,6,7-trihydroxy-1-oxo-3-(1,2,3,4-tetrahydroxybutyl)-1H-isochromen-8-yl]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

C27H18O17 (614.0543978000001)

Castacrenin C is found in nuts. Castacrenin C is a constituent of the heartwood of Castanea crenata (Japanese chestnut)

6-Cinnamoyl-1,2-digalloylglucose

4,5-Dihydroxy-6-({[(2E)-3-phenylprop-2-enoyl]oxy}methyl)-2-(3,4,5-trihydroxybenzoyloxy)oxan-3-yl 3,4,5-trihydroxybenzoic acid

C29H26O15 (614.1271646)

6-Cinnamoyl-1,2-digalloylglucose is found in green vegetables. 6-Cinnamoyl-1,2-digalloylglucose is isolated from commercial rhubarbs (Rheum species). Isolated from commercial rhubarbs (Rheum subspecies). 6-Cinnamoyl-1,2-digalloylglucose is found in green vegetables.

Castacrenin B

6,7,13,14-tetrahydroxy-12-[5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-11-yl]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0543978000001)

Castacrenin B is found in nuts. Castacrenin B is a constituent of the heartwood of Castanea crenata (Japanese chestnut)

Fosaprepitant

(3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid

C23H22F7N4O6P (614.1165126)

Fosaprepitant is only found in individuals that have used or taken this drug. It is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment.Aprepitant has been shown in animal models to inhibit emesis induced by cytotoxic chemotherapeutic agents, such as cisplatin, via central actions. Animal and human Positron Emission Tomography (PET) studies with Aprepitant have shown that it crosses the blood brain barrier and occupies brain NK1 receptors. Animal and human studies show that Aprepitant augments the antiemetic activity of the 5-HT₃-receptor antagonist ondansetron and the corticosteroid ethasone and inhibits both the acute and delayed phases of cisplatin induced emesis.In summary, the active form of fosaprepitant is as an NK1 antagonist which is because it blocks signals given off by NK1 receptors. This therefore decreases the likelihood of vomiting in patients experiencing. D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

Lifitegrast

(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid

C29H24Cl2N2O7S (614.0681214)

An organic heterotetracyclic compound isolated from the culture broth of Micromonospora sp. SA-246. It exhibits potent antibacterial activity against several Gram-positive bacterial strains.

Edgeworoside B

C32H22O13 (614.1060362000001)

bromophycolide J

C28H40Br2O5 (614.124231)

kaempferol 3-O-(2-O-galloyl)-glucuronide

C28H22O16 (614.0907812)

nakiterpiosinone

C27H29BrCl2O7 (614.0473604)

beta-D-Pyranose-6-Cinnamoyl-1, 2-digalloylglucose

C29H26O15 (614.1271646)

4-galloyl-3,3-di-O-methylellagic acid 4-O-beta-D-xylopyranoside

C28H22O16 (614.0907812)

Sparin A

C32H22O13 (614.1060362000001)

3-methoxy-7-O-beta-(6-galloylglucopyranoside)quercetin

C29H26O15 (614.1271646)

Fosaprepitant

(3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid

C23H22F7N4O6P (614.1165126)

D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

Castacrenin A

5-[4-(1,2-dihydroxyethyl)-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0^{2,6}]trideca-1(9),10,12-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0543978000001)

Castacrenin B

6,7,13,14-tetrahydroxy-5-[5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0^{2,7}]tetradeca-1(10),11,13-trien-11-yl]-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0543978000001)

Castacrenin C

6,7,13,14-tetrahydroxy-5-[5,6,7-trihydroxy-1-oxo-3-(1,2,3,4-tetrahydroxybutyl)-1H-isochromen-8-yl]-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0543978000001)

2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose

4,5-dihydroxy-3-{[(2Z)-3-phenylprop-2-enoyl]oxy}-6-{[(3,4,5-trihydroxyphenyl)carbonyloxy]methyl}oxan-2-yl 3,4,5-trihydroxybenzoate

C29H26O15 (614.1271646)

6-Cinnamoyl-1,2-digalloylglucose

4,5-dihydroxy-6-({[(2E)-3-phenylprop-2-enoyl]oxy}methyl)-3-[(3,4,5-trihydroxyphenyl)carbonyloxy]oxan-2-yl 3,4,5-trihydroxybenzoate

C29H26O15 (614.1271646)

Akt Inhibitor IV

C31H27IN4S (614.1001092)

Lifitegrast

C29H24Cl2N2O7S (614.0681214)

D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions C78283 - Agent Affecting Organs of Special Senses S - Sensory organs > S01 - Ophthalmologicals

Acebrophylline

C22H28Br2N6O5 (614.0487798)

2,7-Dibromo-9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-9H-fluorene

C27H36Br2O6 (614.0878476)

dCMP64dCMP_dewar

C18H28N6O14P2 (614.1138688)

dCMP64dCMP

C18H28N6O14P2 (614.1138688)

GDP-N-formyl-alpha-D-perosamine

C17H24N6O15P2-2 (614.0774854)

dCMP dimer

C18H28N6O14P2 (614.1138688)

6-[1-(7-Chloro-3,5,6,8-tetramethoxy-4-oxochromen-2-yl)-3-methoxy-4-oxocyclohexa-2,5-dien-1-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H27ClO15 (614.1038422)

2-deoxycytidine 5-monophosphate dimer

C18H28N6O14P2 (614.1138688)

A cyclobutadipyrimidine bis(deoxyribonucleotide) obtained by formal cyclodimerisation of 2-deoxycytidine 5-monophosphate.

5,6-diamino-1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-4,5-dihydro[4,4-bipyrimidine]-2,2(1H,3H)-dione

C18H28N6O14P2 (614.1138688)

An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.

1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-6-(5,6-diamino-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl)-1,3-diazabicyclo[2.2.0]hex-4-en-2-one

C18H28N6O14P2 (614.1138688)

An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.

(E)-Akt inhibitor-IV

C31H27IN4S (614.1001092)

(E)-Akt inhibitor-IV ((E)-AKTIV) is a PI3K-Akt inhibitor, with potent cytotoxic[1].

(11s,15s,17r)-7,17-dihydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

(11s,15s,17r)-7,17-dihydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

C32H22O13 (614.1060362000001)

7'-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-7-hydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione

C32H22O13 (614.1060362000001)

3,5-dihydroxy-2-{3-hydroxy-4-[2-methoxy-4-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]phenyl}-7-methoxychromen-4-one

C32H22O13 (614.1060362000001)

5-[4-(1,2-dihydroxyethyl)-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

5-[4-(1,2-dihydroxyethyl)-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

C27H18O17 (614.0543978000001)

17-methyl-5-{2,7,9-trihydroxy-17-methyl-13-oxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1,3,5,7,9-pentaen-5-yl}-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),5-triene-2,4,7,9,13-pentone

17-methyl-5-{2,7,9-trihydroxy-17-methyl-13-oxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1,3,5,7,9-pentaen-5-yl}-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),5-triene-2,4,7,9,13-pentone

C32H22O13 (614.1060362000001)

(1s,2s,4r,12s,13r,15r,16s)-2-bromo-8-[(2r,3s)-1,1-dichloro-3-hydroxy-3-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]propan-2-yl]-16-hydroxy-9,13-dimethyl-18-oxapentacyclo[13.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰]octadeca-5(10),6,8-triene-11,17-dione

(1s,2s,4r,12s,13r,15r,16s)-2-bromo-8-[(2r,3s)-1,1-dichloro-3-hydroxy-3-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]propan-2-yl]-16-hydroxy-9,13-dimethyl-18-oxapentacyclo[13.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰]octadeca-5(10),6,8-triene-11,17-dione

C27H29BrCl2O7 (614.0473604)

7,14-dimethoxy-3,10-dioxo-13-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaen-6-yl 3,4,5-trihydroxybenzoate

C28H22O16 (614.0907812)